Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerald Denk

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
JHEP Reports : Innovation in Hepatology|March 14, 2026
Evaluation of novel assays of non-ceruloplasmin copper to monitor chelation treatment in patients with Wilson disease: Monitoring chelation treatment in Wilson diseasePeter Ott, Thomas Sandahl, Aftab Ala, et al.
The Lancet. Gastroenterology & Hepatology|October 2, 2022
Trientine tetrahydrochloride versus penicillamine for maintenance therapy in Wilson disease (CHELATE): a randomised, open-label, non-inferiority, phase 3 trialMichael L Schilsky, Anna Czlonkowska, Massimo Zuin, et al.
Aging and Disease|June 12, 2023
The inhibition of YAP Signaling Prevents Chronic Biliary Fibrosis in the Abcb4<sup>-/-</sup> Model by Modulation of Hepatic Stellate Cell and Bile Duct Epithelium Cell PathophysiologyLiangtao Ye, Andreas Ziesch, Julia S Schneider, et al.
JHEP Reports : Innovation in Hepatology|August 14, 2024
Non-ceruloplasmin copper and urinary copper in clinically stable Wilson disease: Alignment with recommended targetsPeter Ott, Thomas Sandahl, Aftab Ala, et al.
Cellular Oncology (Dordrecht, Netherlands)|June 16, 2025
Efficacy of CDK4/6 Inhibition in colorectal cancer and the role of p16 expression in predicting drug resistanceJulia S Schneider, Najib Ben Khaled, Liangtao Ye, et al.
Journal of Clinical Medicine|July 29, 2020
Prevention and Management of CMV Infections after Liver Transplantation: Current Practice in German Transplant CentersCornelius Engelmann, Martina Sterneck, Karl Heinz Weiss, et al.
Mitochondrion|September 23, 2017
Mitochondrial adaptation in steatotic miceClaudia Einer, Simon Hohenester, Ralf Wimmer, et al.
Data in Brief|October 17, 2017
Data on chow, liver tissue and mitochondrial fatty acid compositions as well as mitochondrial proteome changes after feeding mice a western diet for 6-24 weeksClaudia Einer, Simon Hohenester, Ralf Wimmer, et al.
Cellular and Molecular Gastroenterology and Hepatology|December 27, 2018
A High-Calorie Diet Aggravates Mitochondrial Dysfunction and Triggers Severe Liver Damage in Wilson Disease RatsClaudia Einer, Christin Leitzinger, Josef Lichtmannegger, et al.
The Journal of Clinical Investigation|June 21, 2016
Methanobactin reverses acute liver failure in a rat model of Wilson diseaseJosef Lichtmannegger, Christin Leitzinger, Ralf Wimmer, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
JHEP Reports : Innovation in Hepatology|March 14, 2026
Evaluation of novel assays of non-ceruloplasmin copper to monitor chelation treatment in patients with Wilson disease: Monitoring chelation treatment in Wilson diseasePeter Ott, Thomas Sandahl, Aftab Ala, et al.
The Lancet. Gastroenterology & Hepatology|October 2, 2022
Trientine tetrahydrochloride versus penicillamine for maintenance therapy in Wilson disease (CHELATE): a randomised, open-label, non-inferiority, phase 3 trialMichael L Schilsky, Anna Czlonkowska, Massimo Zuin, et al.
Aging and Disease|June 12, 2023
The inhibition of YAP Signaling Prevents Chronic Biliary Fibrosis in the Abcb4<sup>-/-</sup> Model by Modulation of Hepatic Stellate Cell and Bile Duct Epithelium Cell PathophysiologyLiangtao Ye, Andreas Ziesch, Julia S Schneider, et al.
JHEP Reports : Innovation in Hepatology|August 14, 2024
Non-ceruloplasmin copper and urinary copper in clinically stable Wilson disease: Alignment with recommended targetsPeter Ott, Thomas Sandahl, Aftab Ala, et al.
Cellular Oncology (Dordrecht, Netherlands)|June 16, 2025
Efficacy of CDK4/6 Inhibition in colorectal cancer and the role of p16 expression in predicting drug resistanceJulia S Schneider, Najib Ben Khaled, Liangtao Ye, et al.
Journal of Clinical Medicine|July 29, 2020
Prevention and Management of CMV Infections after Liver Transplantation: Current Practice in German Transplant CentersCornelius Engelmann, Martina Sterneck, Karl Heinz Weiss, et al.
Mitochondrion|September 23, 2017
Mitochondrial adaptation in steatotic miceClaudia Einer, Simon Hohenester, Ralf Wimmer, et al.
Data in Brief|October 17, 2017
Data on chow, liver tissue and mitochondrial fatty acid compositions as well as mitochondrial proteome changes after feeding mice a western diet for 6-24 weeksClaudia Einer, Simon Hohenester, Ralf Wimmer, et al.
Cellular and Molecular Gastroenterology and Hepatology|December 27, 2018
A High-Calorie Diet Aggravates Mitochondrial Dysfunction and Triggers Severe Liver Damage in Wilson Disease RatsClaudia Einer, Christin Leitzinger, Josef Lichtmannegger, et al.
The Journal of Clinical Investigation|June 21, 2016
Methanobactin reverses acute liver failure in a rat model of Wilson diseaseJosef Lichtmannegger, Christin Leitzinger, Ralf Wimmer, et al.
Pageof 6